maleic anhydride has been researched along with Carcinoma, Renal Cell in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (16.67) | 18.7374 |
| 1990's | 2 (33.33) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Greish, K; Maeda, H; Nagamitsu, A | 1 |
| Asano, T; Hayakawa, M; Ito, K; Kaji, T; Kimura, F; Sumitomo, M; Takahashi, E; Umeda, S | 1 |
| Kakinuma, H; Kato, T; Sato, K | 1 |
| Kobayashi, M; Konno, T; Maeda, H; Tsuchiya, K; Uchida, T; Yamanaka, H | 1 |
| Imai, K; Kobayashi, M; Konno, T; Maeda, H; Sugihara, S; Yamanaka, H | 1 |
| Imai, K; Kobayashi, M; Konno, T; Maeda, H; Nakamura, T; Suzuki, K; Suzuki, T; Takahashi, O; Yamanaka, H | 1 |
1 review(s) available for maleic anhydride and Carcinoma, Renal Cell
| Article | Year |
|---|---|
[Targeting therapy for renal cancer].
Topics: Brachytherapy; Carcinoma, Renal Cell; Chemoembolization, Therapeutic; Humans; Kidney Neoplasms; Maleic Anhydrides; Mitomycin; Polystyrenes; Survival Rate; Zinostatin | 1994 |
5 other study(ies) available for maleic anhydride and Carcinoma, Renal Cell
| Article | Year |
|---|---|
Elevating blood pressure as a strategy to increase tumor-targeted delivery of macromolecular drug SMANCS: cases of advanced solid tumors.
Topics: Adenocarcinoma; Adult; Aged; Angiotensin II; Antineoplastic Agents; Blood Pressure; Carcinoma, Renal Cell; Cholangiocarcinoma; Drug Delivery Systems; Female; Humans; Hypertension; Infusions, Intravenous; Japan; Kidney Neoplasms; Liver Neoplasms; Male; Maleic Anhydrides; Middle Aged; Neoplasm Staging; Neoplasms; Ovarian Neoplasms; Pancreatic Neoplasms; Polystyrenes; Vasoconstrictor Agents; Zinostatin | 2009 |
[Clinical experience of treatment of liver metastasis of renal cell carcinoma treated with SMANCS/Lipiodol therapy].
Topics: Adult; Aged; Antineoplastic Agents; Carcinoma, Renal Cell; Ethiodized Oil; Female; Humans; Infusions, Intra-Arterial; Kidney Neoplasms; Liver Neoplasms; Male; Maleic Anhydrides; Middle Aged; Polystyrenes; Zinostatin | 2010 |
Tumor-targeted chemotherapy with SMANCS in lipiodol for renal cell carcinoma: longer survival with larger size tumors.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Carcinoma, Renal Cell; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Infusions, Intra-Arterial; Iodized Oil; Kidney Neoplasms; Male; Maleic Anhydrides; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Polystyrenes; Survival Rate; Tomography, X-Ray Computed; Treatment Outcome; Zinostatin | 2000 |
Tumor-targeted chemotherapy with lipid contrast medium and macromolecular anticancer drug (SMANCS) for renal cell carcinoma.
Topics: Adult; Aged; Antineoplastic Agents; Carcinoma, Renal Cell; Female; Humans; Infusions, Intra-Arterial; Iodized Oil; Kidney Neoplasms; Male; Maleic Anhydrides; Middle Aged; Polystyrenes; Zinostatin | 1991 |
[Histological effect of SMANCS/LPD therapy in renal cell carcinoma].
Topics: Adult; Aged; Antibiotics, Antineoplastic; Carcinoma, Renal Cell; Embolization, Therapeutic; Female; Furans; Humans; Iodized Oil; Kidney Neoplasms; Male; Maleic Anhydrides; Middle Aged; Polystyrenes; Zinostatin | 1987 |